GPCR
Structure Therapeutics Inc. NASDAQ Listed Feb 3, 2023$39.05
Mkt Cap $2.2B
52w Low $15.80
29.4% of range
52w High $94.90
50d MA $51.72
200d MA $45.02
P/E (TTM)
-17.6x
EV/EBITDA
-24.3x
P/B
1.6x
Debt/Equity
0.0x
ROE
-9.3%
P/FCF
-18.2x
RSI (14)
—
ATR (14)
—
Beta
-1.25
50d MA
$51.72
200d MA
$45.02
Avg Volume
959.3K
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
611 Gateway Boulevard · South San Francisco, CA 94080 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.39 | -0.35 | +10.3% | 39.15 | -2.5% | -0.1% | — | — | — | — | — |
| Feb 26, 2026 | AMC | -0.35 | -0.49 | -40.0% | 64.75 | -1.0% | -2.7% | -2.9% | -2.6% | -2.5% | -7.8% | — |
| Nov 6, 2025 | AMC | -0.36 | -0.37 | -2.8% | 33.47 | +0.7% | -1.9% | +1.3% | +4.2% | +7.3% | +4.6% | — |
| Aug 6, 2025 | AMC | -0.28 | -0.36 | -28.6% | 16.31 | +8.5% | -0.7% | +0.0% | +7.4% | +14.9% | +17.5% | — |
| May 8, 2025 | AMC | -0.24 | -0.27 | -12.5% | 26.82 | -0.6% | -4.7% | -8.2% | -10.9% | -11.2% | -8.9% | — |
| Feb 27, 2025 | AMC | -0.23 | -0.22 | +4.3% | 22.82 | +1.7% | +4.1% | -2.1% | -1.4% | -1.1% | +3.1% | — |
| Nov 13, 2024 | AMC | -0.19 | -0.20 | -5.3% | 36.37 | -1.0% | +3.6% | -6.0% | -12.7% | -9.9% | -10.1% | — |
| Aug 8, 2024 | AMC | -0.23 | -0.18 | +21.7% | 34.49 | +4.3% | -2.1% | -3.8% | -0.5% | +5.1% | +5.9% | — |
| May 9, 2024 | AMC | -0.21 | -0.19 | +9.5% | 38.65 | -4.5% | -7.3% | -6.9% | -7.6% | -6.7% | -7.2% | — |
| Mar 8, 2024 | AMC | -0.21 | -0.17 | +19.0% | 36.86 | +1.9% | -4.7% | -4.3% | -8.0% | -4.6% | -4.4% | — |
| Nov 14, 2023 | AMC | -0.29 | -0.62 | -113.8% | 53.59 | +0.9% | -9.8% | -10.5% | +0.3% | -0.2% | -4.2% | — |
| Aug 10, 2023 | AMC | -0.28 | -0.60 | -114.3% | 29.35 | -3.5% | -6.1% | -7.6% | -7.0% | -7.7% | -6.2% | — |
| May 11, 2023 | AMC | -0.41 | -0.25 | +39.0% | 25.00 | +1.5% | +5.6% | +4.0% | -1.2% | -7.1% | -9.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Canaccord Genuity | Initiates | Buy | $101 | $45.49 | $45.79 | +0.7% | -0.4% | -4.2% | -9.1% | -8.9% | -7.2% |
| Mar 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $53.75 | $56.58 | +5.3% | +5.4% | +4.5% | -3.5% | -6.1% | -9.6% |
| Mar 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.98 | $61.88 | -1.7% | -0.1% | +0.1% | +0.2% | -5.2% | -8.3% |
| Feb 27 | Citizens | Maintains | Market Outperform → Market Outperform | — | $64.75 | $64.13 | -1.0% | -2.7% | -2.9% | -2.6% | -2.5% | -7.8% |
| Jan 22 | JP Morgan | Maintains | Overweight → Overweight | — | $93.79 | $93.79 | +0.0% | -2.0% | -3.6% | -4.5% | -4.6% | -5.1% |
| Jan 20 | Guggenheim | Maintains | Buy → Buy | — | $88.64 | $88.36 | -0.3% | +2.7% | +5.8% | +3.6% | +2.0% | +1.0% |
| Dec 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.45 | $66.03 | +5.7% | +4.0% | +1.3% | +14.2% | +11.6% | +9.4% |
| Dec 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $67.44 | $68.61 | +1.7% | -0.6% | -3.9% | -8.5% | -11.1% | -7.4% |
| Dec 12 | Citizens | Maintains | Market Outperform → Market Outperform | — | $67.44 | $68.61 | +1.7% | -0.6% | -3.9% | -8.5% | -11.1% | -7.4% |
| Dec 11 | Jefferies | Maintains | Buy → Buy | — | $68.94 | $69.30 | +0.5% | -2.2% | -2.7% | -6.0% | -10.5% | -13.0% |
| Dec 9 | Stifel | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | -1.5% | -3.6% | -4.2% | -7.4% |
| Dec 9 | Clear Street | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | -1.5% | -3.6% | -4.2% | -7.4% |
| Dec 9 | Citigroup | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | -1.5% | -3.6% | -4.2% | -7.4% |
| Aug 7 | Guggenheim | Maintains | Buy → Buy | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.0% | +7.4% | +14.9% | +17.5% |
| Aug 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.0% | +7.4% | +14.9% | +17.5% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.0% | +7.4% | +14.9% | +17.5% |
| Jun 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $21.73 | $21.91 | +0.8% | +1.7% | +3.0% | +0.3% | -3.0% | -3.0% |
| Jun 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $21.73 | $21.91 | +0.8% | +1.7% | +3.0% | +0.3% | -3.0% | -3.0% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.57 | $26.38 | +3.2% | -3.7% | -6.6% | -6.8% | -4.5% | -1.6% |
| Apr 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.10 | $23.17 | +0.3% | -0.3% | +1.0% | +2.4% | +2.8% | +2.3% |
| Feb 28 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $22.82 | $23.20 | +1.7% | +4.1% | -2.1% | -1.4% | -1.1% | +3.1% |
| Dec 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.97 | $30.79 | +2.7% | -6.9% | -4.6% | -5.7% | -1.4% | -3.1% |
| Dec 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $27.90 | $27.42 | -1.7% | +7.4% | +0.0% | +2.4% | +1.3% | +5.9% |
| Dec 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $31.48 | $29.60 | -6.0% | -11.4% | -4.8% | -11.4% | -9.2% | -10.3% |
| Sep 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $41.92 | $45.00 | +7.3% | +1.0% | +5.0% | +0.1% | -0.9% | -0.4% |
| Sep 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $40.84 | $40.63 | -0.5% | -2.1% | -5.9% | -6.3% | -5.1% | +2.6% |
| Sep 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $36.95 | $37.13 | +0.5% | -4.7% | -6.8% | +7.3% | +9.0% | +10.5% |
| Aug 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.12 | $37.23 | +0.3% | +8.0% | +8.5% | +6.8% | +5.5% | +7.2% |
| Aug 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $36.24 | $36.83 | +1.6% | +0.7% | +2.4% | +10.7% | +11.1% | +9.4% |
| Aug 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $34.49 | $35.97 | +4.3% | -2.1% | -3.8% | -0.5% | +5.1% | +5.9% |
| Jul 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $39.27 | $40.01 | +1.9% | +1.9% | -1.4% | -4.6% | -3.8% | -5.2% |
| Jun 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $47.52 | $46.91 | -1.3% | -1.6% | -4.1% | -8.1% | -15.9% | -20.3% |
| Jun 17 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $48.17 | $48.39 | +0.5% | +0.9% | -1.3% | -2.9% | -5.4% | -9.3% |
| Jun 7 | BMO Capital | Maintains | Outperform → Outperform | — | $55.63 | $55.66 | +0.1% | -4.6% | -4.9% | -10.0% | -6.5% | -7.2% |
| Jun 3 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $34.20 | $35.45 | +3.7% | +54.2% | +58.7% | +64.6% | +62.7% | +55.2% |
| May 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $38.65 | $36.92 | -4.5% | -7.3% | -6.9% | -7.6% | -6.7% | -7.2% |
| May 3 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $38.99 | $39.55 | +1.4% | +0.8% | +1.9% | +0.9% | +0.6% | -0.9% |
| Apr 18 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.07 | $36.93 | -0.4% | -2.4% | -1.9% | -2.8% | -2.6% | -1.7% |
| Mar 8 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $36.01 | $36.79 | +2.2% | +2.4% | -2.5% | -2.0% | -5.9% | -2.3% |
| Nov 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $53.77 | $54.67 | +1.7% | -0.6% | -4.5% | -4.5% | -4.2% | -2.5% |
| Nov 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $53.59 | $54.09 | +0.9% | -9.8% | -10.5% | +0.3% | -0.2% | -4.2% |
| Oct 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.00 | $69.00 | -1.4% | -2.6% | -0.4% | +6.1% | +5.5% | +2.7% |
| Oct 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.61 | $68.85 | +1.8% | +3.5% | +0.8% | +3.1% | +9.9% | +9.3% |
| Oct 3 | BMO Capital | Maintains | Outperform → Outperform | — | $56.60 | $58.04 | +2.5% | +4.1% | -3.6% | -2.8% | -2.6% | +2.5% |
| Sep 29 | Jefferies | Maintains | Buy → Buy | — | $37.47 | $65.09 | +73.7% | +34.6% | +51.1% | +57.3% | +45.6% | +46.9% |
| Feb 28 | Jefferies | Maintains | Buy → Buy | — | $24.00 | $24.20 | +0.8% | +6.5% | -4.5% | -4.9% | +10.6% | +8.3% |
| Feb 28 | BMO Capital | Maintains | Outperform → Outperform | — | $24.00 | $24.20 | +0.8% | +6.5% | -4.5% | -4.9% | +10.6% | +8.3% |
| Feb 28 | Guggenheim | Maintains | Buy → Buy | — | $24.00 | $24.20 | +0.8% | +6.5% | -4.5% | -4.9% | +10.6% | +8.3% |
No insider trades available.
Data updated apr 26, 2026 10:44am
· Source: massive.com